Merkle, J.; Breunig, M.; Schmid, M.; Allgöwer, C.; Krüger, J.; Melzer, M.K.; Bens, S.; Siebert, R.; Perkhofer, L.; Azoitei, N.;
et al. CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome. Cancers 2021, 13, 5139.
https://doi.org/10.3390/cancers13205139
AMA Style
Merkle J, Breunig M, Schmid M, Allgöwer C, Krüger J, Melzer MK, Bens S, Siebert R, Perkhofer L, Azoitei N,
et al. CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome. Cancers. 2021; 13(20):5139.
https://doi.org/10.3390/cancers13205139
Chicago/Turabian Style
Merkle, Jessica, Markus Breunig, Maximilian Schmid, Chantal Allgöwer, Jana Krüger, Michael K. Melzer, Susanne Bens, Reiner Siebert, Lukas Perkhofer, Ninel Azoitei,
and et al. 2021. "CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome" Cancers 13, no. 20: 5139.
https://doi.org/10.3390/cancers13205139
APA Style
Merkle, J., Breunig, M., Schmid, M., Allgöwer, C., Krüger, J., Melzer, M. K., Bens, S., Siebert, R., Perkhofer, L., Azoitei, N., Seufferlein, T., Heller, S., Meier, M., Müller, M., Kleger, A., & Hohwieler, M.
(2021). CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome. Cancers, 13(20), 5139.
https://doi.org/10.3390/cancers13205139